Aarkstore Enterprise || Equine Encephalitis – Pipeline Review, H2 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Equine Encephalitis – Pipeline Review, H2 2012
RSS link of Global Markets Direct
Summary
Global Markets Direct’s, Equine Encephalitis - Pipeline Review, H2 2012, provides
an overview of the Equine Encephalitis therapeutic pipeline. This report provides
information on the therapeutic development for Equine Encephalitis, complete with
latest updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Equine
Encephalitis. Equine Encephalitis - Pipeline Review, H2 2012 is built using data and
information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Equine Encephalitis.
- A review of the Equine Encephalitis products under development by companies
and universities/research institutes based on information derived from company
and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.

2. - A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Table of contents:
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Equine Encephalitis Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Equine Encephalitis 7
Equine Encephalitis Therapeutics under Development by Companies 9
Equine Encephalitis Therapeutics under Investigation by Universities/Institutes 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Pre-Clinical Stage Products 13
Comparative Analysis 13
Equine Encephalitis Therapeutics – Products under Development by Companies 14
Equine Encephalitis Therapeutics – Products under Investigation by
Universities/Institutes 15
Companies Involved in Equine Encephalitis Therapeutics Development 16
CytoGenix, Inc. 16
AlphaVax, Inc. 17
Equine Encephalitis – Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Drug Profiles 23
DNA Vaccines For Bacterial Infections - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Equine Encephalitis Vaccine - Drug Profile 24

3. Product Description 24
Mechanism of Action 24
R&D Progress 24
Western Equine Encephalitis Vaccine - Drug Profile 25
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Nasopharyngeal Cancer – Pipeline Review, H2 2012
Medulloblastoma – Pipeline Review, H2 2012
Ewing Sarcoma – Pipeline Review, H2 2012
Respiratory Syncytial Virus (RSV) Infections – Pipeline Review, H2 2012
Equine Encephalitis – Pipeline Review, H2 2012
Anaplastic Astrocytoma – Pipeline Review, H2 2012
Penile Cancer – Pipeline Review, H2 2012

4. Natural Killer Cell Lymphomas – Pipeline Review, H2 2012
Medullary Thyroid Cancer – Pipeline Review, H2 2012
Fever – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com